NCCN Guidelines for Patients®

Please find cancer guideline resources on this below link:

NCCN offers more than 65 NCCN Guidelines for Patients and Translations in Several Languages.

The NCCN Guidelines for Patients are created in an easy to understand format and are also translated into multiple languages including: English, Arabic, Chinese, French, Haitian, Hindi, Hmong, Italian, Japanese, Korean, Polish, Portuguese, Russian, Somali, Spanish, Tagalog, Ukrainian and Vietnamese.

NCCN Guidelines for Patients® Available from the NCCN

  • Acute Lymphoblastic Leukemia (adult)
  • Acute Myeloid Leukemia
  • Adrenal Tumors
  • Anal Cancer
  • Basal Cell Skin Cancer
  • Lymphomas – e B-Cell
  • Bladder Cancer
  • Bone Cancer
  • Brain Cancer – Gliomas
  • Breast Cancer
  • Central Nervous System Cancers
  • Cervical Cancer
  • Chronic Lymphocytic Leukemia
  • Chronic Myeloid Leukemia
  • Colon Cancer
  • Esophageal Cancer
  • Gallbladder and Bile Duct Cancers
  • Gastrointestinal Stromal Tumors (GIST)
  • Head and Neck Cancers
  • Hodgkin Lymphoma
  • Kidney Cancer
  • Liver Cancer
  • Melanoma
  • Mesothelioma
  • Multiple Myeloma
  • Mycosis fungoides/Sézary Syndrome
  • Myelodysplastic Syndromes
  • Myeloproliferative Neoplasms
  • Neuroendocrine Tumors
  • Non-Small Cell Lung Cancer – Early and Locally Advanced
  • Non-Small Cell Lung Cancer – Metastatic
  • Ovarian Cancer
  • Pancreatic Cancer
  • Peripheral T-Cell Lymphoma
  • Primary Cutaneous Lymphomas
  • Prostate Cancer: Advanced Stage
  • Prostate Cancer: Early Stage
  • Rectal Cancer
  • Small Cell Lung Cancer
  • Soft Tissue Sarcoma
  • Squamous Cell Skin Cancer
  • Stomach Cancer
  • Systemic Mastocytosis
  • Thyroid Cancer
  • Uterine Cancer
  • Waldenström Macroglobulinemia

To view the most recent and complete version of the NCCN Guidelines for Patients, go online to

PET/CT and Cancer

PET Imaging (PET/CT), used at NCPIC, is approved by all insurances including Medicare and Medicaid Services for over 550+ oncology indications.

No Warranties Statement

Referenced with permission from the National Comprehensive Cancer Network, Inc. © National Comprehensive Cancer Network, Inc. 2023.  All rights reserved.  Accessed August 21, 2023. To view the most recent and complete version of the recommendations, go online to NCCN makes no warranties of any kind whatsoever regarding their content, use or application and disclaims any responsibility for their application or use in any way.